Forte Biosciences, Inc. (FBRX) has 11 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: Aug. 27, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 27, 2026 | Kornfeld Steven Director | $0 | 60,313 | −100% | No | |
|
|
||||||
| Aug. 27, 2026 | Brun Scott C. Director | $0 | 54,353 | — | No | |
|
|
||||||
| Aug. 27, 2026 | VINCENT RICHARD G Director | $0 | 51,353 | — | No | |
|
|
||||||
| Aug. 27, 2026 | FINCK BARBARA K Director | $0 | 60,519 | — | No | |
|
|
||||||
| Aug. 27, 2026 | GRYSKA DAVID W Director | $0 | 60,293 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free